retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Eli Lilly's shows promising weight loss results in 3 Retatrutide, a TRIPLE agonist (GLP1,
Description
Santiago JA, Karthikeyan M, Lackey M, Villavicencio D, Potashkin JA
Giacosa A, Guido D, Grassi M, et al
An enzyme called dipeptidyl peptidase-4 (DPP-4) cleaves and inactivates GLP-1 almost instantly, preventing it from reaching therapeutic targets in any meaningful way
Frequently Asked Questions Can someone with type 2 diabetes take GLP-1 medications if they also have a thyroid condition
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
